Ophthalmodynamometry for ICP prediction and pilot test on Mt. Everest

被引:21
|
作者
Querfurth, Henry W. [1 ]
Lieberman, Philip [2 ]
Arms, Steve [3 ]
Mundell, Steve [3 ]
Bennett, Michael [4 ]
van Horne, Craig [4 ]
机构
[1] Brown Univ, Warren Alpert Med Sch, Rhode Isl Hosp, Dept Neurol, Providence, RI 02903 USA
[2] Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA
[3] MicroStrain Inc, Williston, VT 05495 USA
[4] Tufts Univ, Caritas St Elizabeths Med Ctr, Dept Neurosurg, Sch Med, Boston, MA 02135 USA
来源
BMC NEUROLOGY | 2010年 / 10卷
关键词
ACUTE MOUNTAIN-SICKNESS; CEREBRAL-BLOOD-FLOW; OPTIC-NERVE SHEATH; HIGH-ALTITUDE HEADACHE; ENDOTHELIAL GROWTH-FACTOR; RAISED INTRACRANIAL-PRESSURE; HYPOBARIC HYPOXIA; WORKING-MEMORY; RAT-BRAIN; EXPOSURE;
D O I
10.1186/1471-2377-10-106
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: A recent development in non-invasive techniques to predict intracranial pressure (ICP) termed venous ophthalmodynamometry (vODM) has made measurements in absolute units possible. However, there has been little progress to show utility in the clinic or field. One important application would be to predict changes in actual ICP during adaptive responses to physiologic stress such as hypoxia. A causal relationship between raised intracranial pressure and acute mountain sickness (AMS) is suspected. Several MRI studies report that modest physiologic increases in cerebral volume, from swelling, normally accompany subacute ascent to simulated high altitudes. Objectives: 1) Validate and calibrate an advanced, portable vODM instrument on intensive patients with raised intracranial pressure and 2) make pilot, non-invasive ICP estimations of normal subjects at increasing altitudes. Methods: The vODM was calibrated against actual ICP in 12 neurosurgical patients, most affected with acute hydrocephalus and monitored using ventriculostomy/pressure transducers. The operator was blinded to the transducer read-out. A clinical field test was then conducted on a variable data set of 42 volunteer trekkers and climbers scaling Mt. Everest, Nepal. Mean ICPs were estimated at several altitudes on the ascent both across and within subjects. Results: Portable vODM measurements increased directly and linearly with ICP resulting in good predictability (r = 0.85). We also found that estimated ICP increases normally with altitude (10 +/- 3 mm Hg; sea level to 20 +/- 2 mm Hg; 6553 m) and that AMS symptoms did not correlate with raised ICP. Conclusion: vODM technology has potential to reliably estimate absolute ICP and is portable. Physiologic increases in ICP and mild-mod AMS are separate responses to high altitude, possibly reflecting swelling and vasoactive instability, respectively.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Ophthalmodynamometry for ICP prediction and pilot test on Mt. Everest
    Henry W Querfurth
    Philip Lieberman
    Steve Arms
    Steve Mundell
    Michael Bennett
    Craig van Horne
    [J]. BMC Neurology, 10
  • [2] Coping with adversity on Mt. Everest
    Botha, KFH
    [J]. INTERNATIONAL JOURNAL OF PSYCHOLOGY, 2000, 35 (3-4) : 80 - 80
  • [3] Muehrcke's Lines on Mt. Everest
    Windsor, Jeremy S.
    Hart, Nigel
    Rodway, George W.
    [J]. HIGH ALTITUDE MEDICINE & BIOLOGY, 2009, 10 (01) : 87 - 88
  • [4] Body Composition and Hematological Changes Following Ascents of Mt. Aconcagua and Mt. Everest
    Wagner, Dale R.
    [J]. AVIATION SPACE AND ENVIRONMENTAL MEDICINE, 2010, 81 (11): : 1045 - 1048
  • [5] Height of Mt. Everest: Physiological and medical implications
    West, JB
    [J]. HIGH ALTITUDE MEDICINE & BIOLOGY, 2006, 7 (01) : 1 - 2
  • [6] An Overview of Physical Risks in the Mt. Everest Region
    Miner, Kimberley R.
    Mayewski, Paul A.
    Baidya, Saraju K.
    Broad, Kenneth
    Clifford, Heather
    Elmore, Aurora
    Gajurel, Ananta P.
    Giri, Bibek
    Guilford, Sam
    Hubbard, Mary
    Jaskolski, Corey
    Koldewey, Heather
    Li, Wei
    Matthews, Tom
    Napper, Imogen
    Perry, L. Baker
    Potocki, Mariusz
    Priscu, John C.
    Tait, Alex
    Thompson, Richard
    Tuladhar, Subash
    [J]. ONE EARTH, 2020, 3 (05): : 547 - 550
  • [7] Deposition of PFAS 'forever chemicals' on Mt. Everest
    Miner, K. R.
    Clifford, H.
    Taruscio, T.
    Potocki, M.
    Solomon, G.
    Ritari, M.
    Napper, I. E.
    Gajurel, A. P.
    Mayewski, P. A.
    [J]. SCIENCE OF THE TOTAL ENVIRONMENT, 2021, 759
  • [8] Analysis of Land-Atmosphere Interactions over the North Region of Mt. Qomolangma (Mt. Everest)
    Chen, Xuelong
    Su, Zhongbo
    Ma, Yaoming
    Sun, Fangin
    [J]. ARCTIC ANTARCTIC AND ALPINE RESEARCH, 2012, 44 (04) : 412 - 422
  • [10] Flowering and Fruiting Phenology of 24 Plant Species on the North Slope of Mt. Qomolangma (Mt. Everest)
    Zhang Liyun
    Turkington, Roy
    Tang Ya
    [J]. JOURNAL OF MOUNTAIN SCIENCE, 2010, 7 (01) : 45 - 54